This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Related letters  • Similar articles in JAMA  Topic Collections  • Bacterial Infections  • Pulmonary Diseases  • Chronic Obstructive Pulmonary Disease  • Pneumonia  • Statistics and Research Methods  • Drug Therapy  • Adverse Effects  • Drug Therapy, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: We are concerned about possible data discrepancies in the systematic review and meta-analysis of inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease (COPD) by Dr Drummond and colleagues.¹ In the analysis of pneumonia events from the study by Burge et al,² Drummond et al reported 87 of 372 events in the inhaled corticosteroid group vs 101 of 370 events in the control group, reflecting a control event rate that is considerably higher than any other trial in the meta-analysis. However, the trial publication² actually reports on "lower respiratory serious adverse events" rather than pneumonia events. The company trial report from the GlaxoSmithKline Clinical Trial Register (FLTB3054, the identification number for the study by Burge et al) shows that there were only 18 and 8 pneumonia events in the fluticasone and control groups, respectively.³ We believe that a substantial proportion of the lower respiratory serious adverse . . . [Full Text of this Article]

Yoon K. Loke, MD
y.loke@uea.ac.uk
School of Medicine, Health Policy and Practice
University of East Anglia
Norwich, United Kingdom

Sonal Singh, MD, MPH
Department of Medicine
Wake Forest University
Winston-Salem, North Carolina

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Inhaled Corticosteroids in Patients With Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis
M. Bradley Drummond, Elliott C. Dasenbrook, Marshall W. Pitz, David J. Murphy, and Eddy Fan
JAMA. 2008;300(20):2407-2416.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Inhaled Corticosteroids in Patients With Chronic Obstructive Pulmonary Disease
James Wall and Imran Aziz
JAMA. 2009;301(14):1432-1433.
EXTRACT | FULL TEXT  

Inhaled Corticosteroids in Patients With Chronic Obstructive Pulmonary Disease
Finn Radner and Ulf Nihlén
JAMA. 2009;301(14):1433.
EXTRACT | FULL TEXT  

Inhaled Corticosteroids in Patients With Chronic Obstructive Pulmonary Disease—Reply
M. Bradley Drummond and Eddy Fan
JAMA. 2009;301(14):1433-1434.
EXTRACT | FULL TEXT